跳转至内容
Merck
CN

911593

Sigma-Aldrich

NanoFabTx 微流体 - 纳米

device kit for synthesis of 100-200 nm nanoparticles and liposomes

别名:

NanoFabTx 设备套件, 微流控套件, 纳米制剂, 纳米颗粒, 脂质体

登录查看公司和协议定价


About This Item

UNSPSC代码:
12162002
UNSPSC代码:
41121811
NACRES:
NA.23

描述

Microfludic device kit for synthesizing nanparticles

Kit components :

  • Microfluidic chip x 1
  • Tubings and accessories

质量水平

应用

advanced drug delivery

一般描述

NanoFabTx 微流控纳米设备套件是一套即插即用的易用型微流控部件,兼容Dolomite 微流控系统和标准注射泵(未包括)。 该设备套件可结合我们的专用纳米制剂试剂盒使用(请浏览www.sigmaaldrich.com/nanofabtx)生成尺寸100至200nm 的纳米颗粒或脂质体。该设备套件包括全面的操作方案、预装式微流控芯片歧管、管道和必要的配件。

应用

NanoFabTx 微流控纳米设备套件要与NanoFabTx纳米试剂盒(包括909637918075907766)一起使用,用于合成封装药物的脂质体纳米颗粒(LNP) 和封装药物的聚合物纳米颗粒进行靶向给药研究。我们的设备套件利用微流控技术实现窄尺寸分散和高批次间一致性,从而简化LNP制剂和聚合物纳米制剂的配制。微流控芯片歧管(chip manifold)化学性质稳定,可以兼容纳米医学中的各种相关溶剂和药物。微流控芯片的几何尺寸和可控制的流速让用户可以实现100至200纳米的目标颗粒直径、均一的形状和结构。我们基于微流控的工具帮助用户轻松调节合成参数,从而帮助精准医学、药物开发和纳米颗粒癌症治疗领域的科研人员实现封装药物的纳米载体的可扩展合成(scalable synthesis )。

特点和优势

  • 我们的配方科学家开发和测试的基于微流控的分步操作方案
  • 优化纳米颗粒和脂质体中的药物封装和装载效率
  • 从100-200 nm的范围选择最佳纳米颗粒和脂质体尺寸
  • 反应体积小以减少昂贵试剂和药物的浪费

法律信息

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow
Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.

商品

NanoFabTx™ platform accelerates drug development with ready-to-use formulations and microfluidic devices for particle synthesis.

NanoFabTX drug delivery formulation kits and lipids mixes for mRNA, nucleic acid, and small molecule delivery in lipid nanoparticles, liposomes and polymeric nanoparticles prepared using Precision NanoSystems microfluidic NanoAssemblr

Professor Robert K. Prud’homme introduces flash nanoprecipitation (FNP) for nanoparticle fabrication, which is a scalable, rapid mixing process for nanoparticle formulations.

Microfluidic assembly improves polyamine nanoencapsulation of nucleic acids, overcoming challenges like polydispersity and poor reproducibility.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门